GSK (NYSE: GSK) won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on
2 years ago
British drugmaker GSK (NYSE: GSK) cut its forecast for 2024 vaccine sales on Wednesday after quarterly revenue from its blockbuster
On Wednesday, British drugmaker GSK (NYSE: GSK) bought partner CureVac (NASDAQ: CVAC) out of their alliance on influenza and COVID-19
GSK shares (NYSE: GSK) fell as much as 7% on Thursday, a day after a U.S. public health agency narrowed
GSK plc (NYSE: GSK), a British drugmaker, has agreed to settle a lawsuit in the United States regarding its discontinued
3 years ago
